Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled versus intravenous sedation in mechanically ventilated ICU patients
2019-004537-16Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Sep 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of isoflurane in delirium and Post-injection delirium/sedation syndrome (PDSS) (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Occurrence of delirium in intensive care. Started Sep 2020; status: active.
02
Drugs
isoflurane
03
Conditions
deliriumPost-injection delirium/sedation syndrome (PDSS)
Beyond the preview
Go deeper on 2019-004537-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004537-16.